Neuroscience
Expertise: Neuroscience 46 results
Consulting
ISCDD International Meeting
Neuroscience
AD/PD 2026
Parkinson’s disease is one of the fastest-growing neurological disorders worldwide, supported by a robust and diverse clinical research pipeline. As understanding of disease biology continues to advance, there is growing recognition that traditional trial designs and endpoints may not fully...
Parkinson’s disease (PD) affects an estimated 10 million people worldwide, including more than 1.1 million in the United States. With prevalence rising as the population ages, experts warn of a growing public health crisis and an economic burden that exceeds...
Neuroscience
Raising the Bar in Global MDD Research
Neuroscience
Clinical Trials on Alzheimer’s Disease
Neuroscience
Jennifer Stewart
In CNS trials, inconsistent endpoint assessments can jeopardize outcomes. Premier Research offers customized rater training to reduce variability, minimize placebo response, and improve data quality from the start. Powered by our Remarque™ platform, we deliver real-time monitoring, centralized scoring, and...
The Alzheimer’s research landscape is undergoing a fundamental transformation. With disease-modifying therapies now a reality, sponsors must rethink how they design, recruit for, and execute trials—particularly in early-stage and preclinical populations. This guide explores five strategic imperatives that can help...